Solasia Pharma K.K. (4597.T)
JPY 42.0
(2.44%)
JPY 42.0
(2.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 617 Million | 1.09 Billion | 559 Million | 454 Million | 1.31 Billion | 318 Million |
| Cost of Revenue | 280 Million | 430 Million | 185 Million | 209 Million | 65 Million | 213 Million |
| Gross Profit | 337 Million | 662 Million | 374 Million | 245 Million | 1.24 Billion | 105 Million |
| Operating Expenses | 1.47 Billion | 3.13 Billion | 2.79 Billion | 4.36 Billion | 3 Billion | 2.52 Billion |
| Selling, General and Administrative Expenses | 1.07 Billion | 2.25 Billion | 1.94 Billion | 2.43 Billion | 1.86 Billion | 1.06 Billion |
| Research and Development Expenses | 403 Million | 883 Million | 845 Million | 1.92 Billion | 1.13 Billion | 1.46 Billion |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.75 Billion | 3.56 Billion | 2.97 Billion | 4.56 Billion | 3.07 Billion | 2.73 Billion |
| Operating Income | -1.13 Billion | -2.47 Billion | -2.41 Billion | -4.11 Billion | -1.76 Billion | -2.42 Billion |
| Interest Expense | - | 18 Million | 23 Million | 43 Million | 35 Million | 25 Million |
| Income Tax Expense | -22 Million | 56 Million | 35 Million | -32 Million | 70 Million | -23 Million |
| Earnings before Tax | -1.13 Billion | -2.49 Billion | -2.44 Billion | -4.15 Billion | -1.79 Billion | -2.44 Billion |
| Net Income | -1.11 Billion | -2.54 Billion | -2.47 Billion | -4.12 Billion | -1.86 Billion | -2.42 Billion |
| Earnings Per Share Basic | -6.61 | -16.76 | -19.03 | -35.16 | -17.75 | -25.98 |
| Earnings Per Share Diluted | -6.61 | -16.76 | -19.03 | -35.16 | -17.75 | -25.98 |
| Weighted Average Shares Outstanding | 168.13 Million | 151.98 Million | 130.14 Million | 117.37 Million | 105.2 Million | 93.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 168.13 Million | 151.98 Million | 130.14 Million | 117.37 Million | 105.2 Million | 93.23 Million |
| Gross Margin | 0.55 | 0.61 | 0.67 | 0.54 | 0.95 | 0.33 |
| EBIT Margin | -1.03 | -1.78 | -3.44 | -7.97 | -0.98 | -7.13 |
| Profit Margin | -1.80 | -2.33 | -4.43 | -9.09 | -1.43 | -7.62 |
| EBITDA | -635 Million | -1.94 Billion | -1.92 Billion | -3.61 Billion | -1.28 Billion | -2.26 Billion |
| Earnings Before Tax Margin | -1.85 | -2.26 | -4.33 | -9.07 | -1.35 | -7.61 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 60 Million | 11 Million | 617 Million | 15 Million | 73 Million | 309 Million |
| Cost of Revenue | 92 Million | 104 Million | 780 Million | 131 Million | 31 Million | 148 Million |
| Gross Profit | -32 Million | -93 Million | -163 Million | -116 Million | 42 Million | 161 Million |
| Operating Expenses | 271 Million | 215 Million | 976 Million | 236 Million | 366 Million | 378 Million |
| Selling, General and Administrative Expenses | 124 Million | 139 Million | - | 141 Million | 250 Million | 279 Million |
| Research and Development Expenses | 147 Million | 76 Million | - | 95 Million | 116 Million | 99 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 363 Million | 319 Million | 1.75 Billion | 367 Million | 397 Million | 526 Million |
| Operating Income | -303 Million | -308 Million | -1.13 Billion | -352 Million | -324 Million | -217 Million |
| Interest Expense | 3 Million | 10 Million | - | - | 7 Million | - |
| Income Tax Expense | -8 Million | -8 Million | -22 Million | -7 Million | -2 Million | -6 Million |
| Earnings before Tax | -308 Million | -318 Million | -1.13 Billion | -350 Million | -333 Million | -203 Million |
| Net Income | -300 Million | -310 Million | -1.11 Billion | -344 Million | -331 Million | -196 Million |
| Earnings Per Share Basic | -1.57 | -1.78 | - | -2.04 | -1.97 | -1.17 |
| Earnings Per Share Diluted | -1.57 | -1.78 | - | -2.04 | -1.97 | -1.17 |
| Weighted Average Shares Outstanding | 190.98 Million | 174.04 Million | 168.13 Million | 168.62 Million | 168.05 Million | 167.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 190.98 Million | 174.04 Million | 168.13 Million | 168.62 Million | 168.05 Million | 167.98 Million |
| Gross Margin | -0.53 | -8.45 | -0.26 | -7.73 | 0.58 | 0.52 |
| EBIT Margin | -4.48 | -19.55 | - | -15.33 | -2.74 | -0.25 |
| Profit Margin | -5.00 | -28.18 | -1.80 | -22.93 | -4.53 | -0.63 |
| EBITDA | -269 Million | -215 Million | - | -230 Million | -200 Million | -77 Million |
| Earnings Before Tax Margin | -5.05 | -28.00 | -1.85 | -23.47 | -4.44 | -0.70 |
IDEXF
TURSG
NIKHILAD
NORBTEAEXP
ARMX
MPG